Form 4 for NPCE NeuroPace Inc
Accepted 2022-03-07 00:00:00 ET · period of report 2022-03-03 · accession 0001209191-22-016875 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-07 | 2022-03-03 | NPCE | Kuhn Rebecca | CFO | A - Grant | $0.00 | +46.7K | 58.3K | +405% | $0 |
| D | 2022-03-07 | 2022-03-03 | NPCE | Kuhn Rebecca | CFO | A - Grant | $0.00 | +93.5K | 93.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-03 | A | A | 46,740 | $0.00 | 58,276 | D | — | — | (F1) Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on March 3, 2023 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-03-03 | A | A | 93,480 | $0.00 | 93,480 | D | $8.15 · 2022-03-03 to 2032-03-02 | 93,480 Common Stock | (F2) 25% of the shares subject to the option vest on March 3, 2023. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. The option is early exercisable. |